logo
Plus   Neg
Share
Email

Ryman Hospitality Properties Slips To Loss In Q4 - Quick Facts

Ryman Hospitality Properties Inc. (RHP) reported that its fourth-quarter loss from continuing operations was $14.9 million, or $0.32 per share compared to income from continuing operations of $5.1 million, or $0.10 per share, in the prior-year quarter.

Loss from continuing operations for the fourth quarter of 2012 included $44.2 million in pretax expenses related to the Company's conversion to a REIT and the impact of a $20 million pretax gain on the sale of brand rights to Marriott.

Income from continuing operations in the fourth quarter of 2011 included a non-cash pre-tax charge of $4.7 million to dispose of fixed assets related to the development of new resort pools and a room renovation at Gaylord Palms.

Consolidated revenue for the fourth quarter of 2012 of $266.3 million was slightly favorable compared to the prior-year quarter consolidated revenue of $265.5 million, as adjusted to reflect the elimination of $3.9 million in retail revenues from the prior-year period from functions that were outsourced in 2012, or a 1.1 percent decrease from prior-year quarter consolidated revenue of $269.4 million without such adjustment.

Analysts polled by Thomson Reuters expected the company to report earnings of $0.26 per share on revenues of $282.01 million for the quarter. Analysts' estimates typically exclude special items.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
An administrative law judge has ruled that Minnesota regulators should approve Enbridge Inc.'s proposal to replace its aging Line 3 crude oil pipeline only if the company follows the existing route and not its preferred route. Enbridge has applied to replace its Line 3 pipeline from Alberta with new pipe along its existing route. In Minnesota, the planned route deviates from the existing route. CLICK HERE to see America's 10 Best-Selling Drugs Despite high drug costs, most of the top-selling drugs saw sales gains in 2017 compared to the prior year. A large number of the best-selling drugs are primarily for the treatment and management of cancer, diabetes, inflammatory disorders, and HIV... Most Americans have access to health care, though costs and services vary from state to state. However, higher costs do not necessarily translate into better results. The U.S. continues to be outperformed by other wealthy nations on several measures like life expectancy, disease burden and health...
Follow RTT